Home » Acorda Therapeutics: Study Shows 5-Milligram Dose of Ampyra Not Effective
Acorda Therapeutics: Study Shows 5-Milligram Dose of Ampyra Not Effective
Acorda Therapeutics said a post-marketing commitment study failed to confirm a five-milligram dose of its dalfampridine-ER improved walking in people with multiple sclerosis.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May